Priority Date: 14.04.06 (US 20060792293P)

USE OF IL-I ANTIBODIES FOR TREATING OPHTHALMIC DISORDERS

  • Application ID: EP07755421
  • Status: The application is deemed to be withdrawn

Applicants

Technology company logo small
Technology Company
Technology company logo small
Technology Company

Attorney

no operation time available
1 office
Technology Company

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Novartis Pharma AG is specialized in A61. Novartis Pharma AG is specialised in A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 14.04.2006 - Priority Date (US 20060792293P)
  • 25.10.2007 - Publication A1 (WO2007120828)
  • 11.02.2009 - Publication A1 (EP2021026)

IPC Classification